eTect was founded in October 2009 with the mission of enabling new classes of in vivo communications applications based on the technologies developed in conjunction with the University of Florida and Convergent Engineering, Inc. The Company brings together a diverse collection of world-class talent in signal processing, in vivo communications, pharmaceutical research and pharmacodynamics, advanced materials, and integrated circuit design. It leverages the talent and experience found in the University of Florida's renowned colleges of engineering, medicine, and pharmacy.
Dr. Neil R. Euliano II, Ph. D., Chief Executive Officer
Dr. Euliano is the founder and President of Convergent Engineering Inc., a Biomedical Engineering firm specializing in signal processing algorithms. Dr. Euliano has been published over forty times, currently holds nine issued patents with approximately twenty pending patents, and has been the principal investigator for multiple programs for the National Institutes for Health, National Science Foundation, and industry sponsors.
D. Eric Buffkin Jr., President
Mr. Buffkin is an entrepreneur and executive with over 20 years of experience in the networking and communications integrated circuits market. He is the founder of Pelagic Group, a consultancy focused on new technology companies. He has also founded or co-founded ventures that span many facets of the wireless semiconductor and communications industry. Mr. Buffkin holds a BSEE from the University of Florida and an MBA from Rollins College, Winter Park, Florida.
Rizwan Bashirullah, Ph.D., Chief Science Officer
Dr. Bashirullah is an Assistant Professor in Electrical and Computer Engineering at the University of Florida. He currently holds four issued patents and his fields of research include biomedical circuits, in vivo wireless interfaces and low power analog/digital VLSI. Dr. Bashirullah holds a Ph.D. in Electrical Engineering from North Carolina State University.
Dr. Brent A. Myers, Ph.D., Technical Lead
Dr. Myers leads a highly experienced, multidisciplinary development team. He is the principal owner of NeoSemi LLC, an IC design firm. He was most recently a co-founder and Director of Mixed-Signal design at Indian River Silicon, a wireless IC development firm. Dr. Myers was a key member of the team who developed the first commercial Wi-Fi chipsets and pioneered that market. His development teams have shipped in excess of 400 million wireless integrated circuits. Dr. Myers holds a Ph.D. in Electrical Engineering from the Florida Institute of Technology. He holds fourteen patents and nine peer-reviewed publications.
J. Daniel Robinson, Pharm.D., Chief Pharmaceutical Officer
Dr. Robinson has written over 20 copyrighted desktop, laptop, handheld, and smart phone applications for improved pharmacokinetic-based dosage regimen design, pharmacy health care outcomes, pharmacoeconomics, pharmaceutical care reimbursement, adverse drug reactions, drug usage evaluation, disease state management, compliance enhancement, and clinical monitoring. During his career at the University of Florida he served as Chairman of the Department of Pharmacy Practice and as Executive Associate Dean of the UF College of Pharmacy. He has written over 100 articles and several books funded by research grants and software development contracts. He holds a BS in Pharmacy from the University of Georgia and a Ph.D. in Pharmacy from the University of Cincinnati.